Showing results (21-30 of 1,470) with videos related to

Sort By:
Pageof 147
Nihon Kokyuki Gakkai Zasshi = the Journal of the Japanese Respiratory Society|November 4, 2000
[A case of multidrug-resistant pulmonary tuberculosis]J Tsurutani, H Sohda, M Oka, et al.
Anticancer Research|August 26, 1998
Lung resistance-related protein gene expression and drug sensitivity in human gastric and lung cancer cellsK Ikeda, M Oka, F Narasaki, et al.
Biochemical and Biophysical Research Communications|November 2, 2001
Transport of 7-ethyl-10-hydroxycamptothecin (SN-38) by breast cancer resistance protein ABCG2 in human lung cancer cellsK Nakatomi, M Yoshikawa, M Oka, et al.
Anticancer Research|January 15, 1998
Enhanced expression of metallothionein in human non-small-cell lung carcinomas following chemotherapyY Matsumoto, M Oka, A Sakamoto, et al.
Japanese Journal of Cancer Research : Gann|February 1, 1997
Gene mutation analysis and quantitation of DNA topoisomerase I in previously untreated non-small cell lung carcinomasH Takatani, M Oka, M Fukuda, et al.
Biochemical and Biophysical Research Communications|March 2, 1999
Direct interaction between a quinoline derivative, MS-209, and multidrug resistance protein (MRP) in human gastric cancer cellsT Nakamura, M Oka, K Aizawa, et al.
Japanese Journal of Cancer Research : Gann|December 1, 1996
The multidrug resistance-associated protein gene confers drug resistance in human gastric and colon cancersM Tomonaga, M Oka, F Narasaki, et al.
European Journal of Cancer (Oxford, England : 1990)|September 3, 2002
Phase I and pharmacokinetic study of paclitaxel and irinotecan for patients with advanced non-small cell lung cancerT Kasai, M Oka, H Soda, et al.
Antimicrobial Agents and Chemotherapy|May 19, 2000
Interactions of ofloxacin and erythromycin with the multidrug resistance protein (MRP) in MRP-overexpressing human leukemia cellsK Terashi, M Oka, H Soda, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 13, 2000
Phase I study of irinotecan combined with carboplatin in previously untreated solid cancersM Fukuda, M Oka, H Soda, et al.
Pageof 147